Skip to Main Content

NEWS & RESOURCES

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs, and…

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address rising…

Content Type:

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the...

Bioscience

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs,...

Bioscience

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address...

Bioscience

Supporting Bioscience Innovation by Removing Major Cost Barrier

Connecticut’s biotechnology sector stands to benefit through legislation currently...

Bioscience

Finance Committee Reviews R&D Tax Credit Expansion

The General Assembly’s Finance, Revenue, and Bonding Committee is considering a significant...

Bioscience

R&D Tax Credit Expansion Draws Strong Support

Connecticut lawmakers are again taking steps to expand access...

Bioscience

Arvinas Appoints Randy Teel as CEO

New Haven-based biotech company Arvinas has appointed Randy Teel as its new president and CEO. ...

Artificial Intelligence

2025 Economic Summit + Outlook, Gov. Lamont

Connecticut Expands AI Workforce Training

Connecticut is expanding investments in key artificial intelligence education and...

Bioscience

R&D Proposal Signals Strong Support for Bioscience

The 2026 legislative session kicked off with significant developments...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.